VI
CORT icon

Versor Investments’s Corcept Therapeutics CORT Stock Holding History

Versor Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,712
Closed -$1.22M – 628
2025
Q3 		$1.22M Buy
+14,712
New +$1.06M 0.23% 69
2025
Q2 		– Sell
-30,648
Closed -$3.5M – 740
2025
Q1 		$3.5M Buy
30,648
+18,448
+151% +$1.12M 0.57% 16
2024
Q4 		$615K Sell
12,200
-12,600
-51% -$660K 0.11% 305
2024
Q3 		$1.15M Buy
+24,800
New +$881K 0.18% 153
2024
Q2 		– Sell
-22,710
Closed -$572K – 759
2024
Q1 		$572K Sell
22,710
-14,668
-39% -$347K 0.12% 293
2023
Q4 		$1.21M Buy
37,378
+14,565
+64% +$400K 0.25% 88
2023
Q3 		$622K Buy
22,813
+11,613
+104% +$336K 0.13% 230
2023
Q2 		$249K Buy
+11,200
New +$258K 0.04% 485
2023
Q1 		– Sell
-29,148
Closed -$592K – 731
2022
Q4 		$592K Buy
29,148
+16,855
+137% +$423K 0.05% 294
2022
Q3 		$315K Sell
12,293
-48,596
-80% -$1.3M 0.02% 583
2022
Q2 		$1.45M Buy
60,889
+42,989
+240% +$937K 0.06% 150
2022
Q1 		$403K Sell
17,900
-5,265
-23% -$112K 0.02% 389
2021
Q4 		$459K Buy
+23,165
New +$470K 0.01% 285
2021
Q2 		– Sell
-14,700
Closed -$350K – 355
2021
Q1 		$350K Buy
+14,700
New +$392K 0.02% 175
2017
Q4 		– Sell
-30,400
Closed -$587K – 248
2017
Q3 		$587K Buy
30,400
+16,600
+120% +$248K 0.19% 56
2017
Q2 		$163K Buy
+13,800
New +$150K 0.04% 178

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Versor Investments's CORT Position: Q4 2025 in Review

Versor Investments sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 14,712 shares — an estimated $1.22M sold.

Versor Investments first reported a position in CORT in Q2 2017 and held it in 16 quarters. The position peaked at $3.5M in Q1 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Versor Investments reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 14,712 Corcept Therapeutics shares in Q4 2025, an estimated $1.22M.
  • Versor Investments first reported a position in Corcept Therapeutics in Q2 2017 and held it in 16 quarters.
  • Versor Investments's Corcept Therapeutics position peaked at $3.5M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.